Publication | Closed Access

Telmisartan improves vascular function and reduces platelet activation in rats with streptozotocin-induced diabetes mellitus

InflammationThrombosisThrombopoiesisVascular FunctionCardiovascular DiseaseBlood PlateletVascular PharmacologyPhysiologyDiabetesPharmacologyStreptozotocin-induced DiabetesVascular BiologyPharmacotherapyMicrovascular DysfunctionMedicineAtherosclerosis